深层脑部刺激器市场按产品类型、应用、最终用户和地区划分

2025 年全球深层脑部刺激器市场规模估计为 16.6 亿美元，预计到 2032 年将达到 33.8 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.7%。

数字。 2025 年深层脑部刺激器市场占有率（按地区）

过去几年，全球深层脑部刺激器市场经历了显着的成长。深部脑部刺激 (DBS) 是一种神经外科手术，透过植入一种称为脑部心律调节器的医疗设备，透过植入的电极向大脑中的特定目标发送电脉衝，以治疗神经和精神疾病。深部脑部刺激可以帮助缓解帕金森氏症、肌张力不全症和自发性震颤的症状。神经设备技术的进步，包括功效更高、电池寿命更长的可充电设备的开发，正在推动 DBS 程式的广泛使用。此外，全球老龄人口不断增长，他们更容易患上神经退化性疾病，这也导致了对深层脑部刺激器的需求不断增长。然而，在预测期内，与设备相关的高成本和程序的复杂性可能会在一定程度上抑制市场的成长。

市场动态：

神经系统疾病盛行率上升、老年人口成长、对先进治疗方案的认识不断提高以及技术发展等关键因素正在推动全球深层脑部刺激器市场的成长。据帕金森基金会称，每年约有 6 万名美国人被诊断出患有帕金森氏症。同样，预计未来几年被诊断出患有阿兹海默症和相关失智症的人数将急剧增加。然而，市场成长可能受到多种因素的限制。深部脑部刺激疗法和设备成本高昂、保险报销范围有限以及缺乏执行复杂 DBS 程序的熟练医疗专业人员是市场面临的一些主要挑战。此外，设备故障问题和新设备漫长的监管核准流程也阻碍了市场扩张。另一方面，持续研究开发具有即时无线编程功能的改进设备并不断提高以患者为中心的护理将为未来几年的市场参与者提供丰厚的机会。

本研究的主要特点

本研究报告对全球深层脑部刺激器市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球深层脑部刺激器市场的主要企业概况。

该研究涉及的主要企业包括雅培、美敦力、波士顿科学公司、Neuropace Inc.、LivaNova Plc、雷尼绍 Plc、Aleva Neurotherapeutics SA、北京品驰医疗器材有限公司、Nexstim、圣犹达医疗（现为雅培的一部分）、Cyber​​BR、Intravex（现为 LC）、Bixk、Intrac Technologies、Scic​​Senc​​ans（现为 LC）、Cyber​​​​iix、Intra 和 Corpccix、Scixc​​​Occ​​​架、Intrac Technologies、Scic​​声al 和Birk 或 Corpk.al.

本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球深层脑部刺激器市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员可以透过用于分析全球深层脑部刺激器市场的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 限制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• PORTER 分析
• 併购情景
• 产业趋势

4. 2020 年至 2032 年全球深层脑部刺激器市场（依产品类型）

• 单通道 DBS 设备
• 双通道DBS设备

5. 2020 年至 2032 年全球深层脑部刺激器市场（依应用划分）

• 癫痫
• 疼痛管理
• 自发性震颤
• 强迫性精神官能症(OCD)
• 帕金森氏症
• 忧郁症
• 肌张力不全症
• 其他的

6. 2020 年至 2032 年全球深层脑部刺激器市场（依最终使用者划分）

• 医院
• 神经科诊所
• 门诊手术中心
• 研究中心
• 其他的

7. 2020 年至 2032 年全球深层脑部刺激器市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• Abbott
• Medtronic
• Boston Scientific Corporation
• Neuropace Inc.
• LivaNova Plc
• Renishaw Plc
• Aleva Neurotherapeutics SA
• Beijing Pinchi Medical Equipment Co. Ltd
• Nexstim
• Jude Medical（now part of Abbott）
• Cyberonics（now part of LivaNova）
• EBR Systems
• IntraPace
• Nevro Corp
• Stimwave Technologies

第九章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Deep Brain Stimulation Devices Market is estimated to be valued at US$ 1.66 Bn in 2025 and is expected to reach US$ 3.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2032.

Figure. Deep Brain Stimulation Devices Market Share (%), By Region 2025

The global deep brain stimulation devices market has been witnessing significant growth over the past few years. Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a brain pacemaker which sends electrical impulses, through implanted electrodes, to specific targets in the brain for treating neurological and psychiatric disorders. Deep brain stimulation helps reduce symptoms of diseases like Parkinson's disease, dystonia, essential tremor among others. Technological advancements in neurological devices like the development of rechargeable devices with improved efficacy and battery life have been fueling the uptake of DBS procedures. Moreover, the growing geriatric population worldwide who are more prone to neurodegenerative disorders has been contributing to the rising demand for deep brain stimulation devices. However, high costs associated with the devices and complexity of procedures might restrain the market growth to some extent during the forecast period.

Market Dynamics:

The key factors such as rising prevalence of neurological disorders, increasing geriatric population, growing awareness about advanced treatment options, and technological developments are fueling the growth of the global deep brain stimulation devices market. According to the Parkinson's Foundation, around 60,000 Americans are diagnosed with Parkinson's disease each year. Similarly, the number of people diagnosed with Alzheimer's disease and related dementias is expected to rise dramatically in coming years. However, the market growth can be restrained by some factors. High costs associated with deep brain stimulation procedures and devices, limited reimbursement coverage and lack of skilled healthcare professionals to perform complex DBS surgeries are some of the major challenges faced by the market. Moreover, issues related to device malfunctions and lengthy approval processes for new devices by regulatory authorities also hinder the market progression. On the flip side, ongoing research for development of improved devices with real-time wireless programming and increased focus on patient-centered care present lucrative opportunities for market players in the coming years.

Key features of the study:

This report provides in-depth analysis of the global deep brain stimulation devices market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global deep brain stimulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, Medtronic, Boston Scientific Corporation, Neuropace Inc., LivaNova Plc, Renishaw Plc, Aleva Neurotherapeutics S.A., Beijing Pinchi Medical Equipment Co. Ltd, Nexstim, St. Jude Medical (now part of Abbott), Cyberonics (now part of LivaNova), EBR Systems, IntraPace, Nevro Corp, Stimwave Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global deep brain stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global deep brain stimulation devices market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Single-channel DBS Devices
  • Dual-channel DBS Devices
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Epilepsy
  • Pain Management
  • Essential Tremor
  • Obsessive Compulsive Disorder (OCD)
  • Parkinson's Disease
  • Depression
  • Dystonia
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Research Centers
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Neuropace Inc.
  • LivaNova Plc
  • Renishaw Plc
  • Aleva Neurotherapeutics S.A.
  • Beijing Pinchi Medical Equipment Co. Ltd
  • Nexstim
  • Jude Medical (now part of Abbott)
  • Cyberonics (now part of LivaNova)
  • EBR Systems
  • IntraPace
  • Nevro Corp
  • Stimwave Technologies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Deep Brain Stimulation Devices Market, By Product Type
  • Global Deep Brain Stimulation Devices Market, By Application
  • Global Deep Brain Stimulation Devices Market, By End User
  • Global Deep Brain Stimulation Devices Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Deep Brain Stimulation Devices Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single-channel DBS Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dual-channel DBS Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Deep Brain Stimulation Devices Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Epilepsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Essential Tremor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Obsessive Compulsive Disorder (OCD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parkinson's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dystonia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Deep Brain Stimulation Devices Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Deep Brain Stimulation Devices Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Neuropace Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LivaNova Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Renishaw Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aleva Neurotherapeutics S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beijing Pinchi Medical Equipment Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nexstim
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jude Medical (now part of Abbott)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyberonics (now part of LivaNova)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EBR Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IntraPace
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nevro Corp
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stimwave Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us